XBI

NYSE_ARCAStock

State Street SPDR S&P Biotech ETF

$123.10-3.32 (-2.63%)

52-Week Range

$69.80

$131.57

Key Stats

Market Cap

6.4B

P/E Ratio

N/A

Dividend Yield

0.00%

Beta

1.47

Volume

9.8M

Avg Volume

10.1M

Performance

+0.83%

+2.64%

+35.27%

YTD

+5.19%

+45.01%

+59.91%

-14.73%

Price Chart

ETF Exposure

XBI is held by 3 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
SECT	Main Sector Rotation ETF	2.44%	156,960	$20.7M	$2.39B	0.78%
NSCS	Nuveen Small Cap Select	0.85%	795	$74K	$7.3M	0.86%
AVTM	Avantis Total Equity Markets ETF 1	0.00%	275	$35K	$694.1M	0.23%

About XBI ETF Exposure

State Street SPDR S&P Biotech ETF (XBI) is held by 3 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 6.4B, XBI is a widely held institutional stock. The stock currently trades at $123.10 with a dividend yield of 0.00%. Investors can gain exposure to XBI through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold XBI, sorted by portfolio weight.